Trump Administration Announces Deal for 150 Million New Rapid COVID-19 Tests

Fourth COVID-19 antigen test approved for emergency use, does not require special machine

President Donald Trump addresses supporters during a campaign rally at Manchester Boston Regional Airport in Londonderry, New Hampshire, on Aug. 28, 2020. Saul Loeb/AFP via Getty Images

The Trump administration on Aug. 27 announced that it has struck a deal to purchase 150 million new rapid COVID-19 tests to be distributed across the United States.

The $760 million deal with U.S. healthcare company Abbott Laboratories was granted emergency use authorization (pdf) by the Food and Drug Administration the day prior, Aug. 26.